Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status.

BioMed research international - 1 Jan 2023

Chen Lizhu, Wen Yaoming, Xiong Jiani, Chen Yu, Chen Chuan-Ben

Abstract excerpt

Immunogenic cell death (ICD) is a type of regulated cell death that can activate adaptive immune response, and its ability to reshape the tumor microenvironment via multiple mechanisms may contribute to immunotherapy. The treatment options for patients with skin cutaneous melanoma (SKCM) vary based on BRAF V600E statuses. However, all standard treatments include immunotherapy. Therefore, it is critical to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Melanoma
Share to Melanoma, Cutaneous Malignant

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 36704723
DOI: 10.1155/2023/1189022
PMCID: PMC9871414

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

An Immunogenic Cell Death-Related Gene Signature Reflects Immune Landscape and Predicts Prognosis in Melanoma Independently of BRAF V600E Status.PMID 36704723Read ↗

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma.Semantic proximity Read ↗

The expression pattern of immune-related genes and characterization of tumor immune microenvironment: predicting prognosis and immunotherapeutic effects in cutaneous melanomaSemantic proximity Read ↗

Identification of an Immune-Related Prognostic Signature Associated With Immune Infiltration in MelanomaSemantic proximity Read ↗

Predicting the clinical outcome of melanoma using an immune-related gene pairs signature.Semantic proximity Read ↗

An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma.Semantic proximity Read ↗

Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanomaSemantic proximity Read ↗

Immuno-Genomic Landscape of Cutaneous Melanoma Identifies a Prognostic and Immunotherapeutically Relevant Gene SignatureSemantic proximity Read ↗

A novel predictive model incorporating immune-related gene signatures for overall survival in melanoma patientsSemantic proximity Read ↗

Ferroptosis-Related Gene Signature Predicts the Prognosis of Skin Cutaneous Melanoma and Response to ImmunotherapySemantic proximity Read ↗

Identification and validation of three risk models in skin melanoma based on bioinformatics analysisSemantic proximity Read ↗

Identification of an Immune-Related Prognostic Signature Associated with Immune Infiltration in MelanomaSemantic proximity Read ↗

Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.